Thought Leadership
When it comes to thought leadership and staying informed, we’ve got you covered. See below for recent articles, webinars, and downloadable resources available.
Want updates like these sent directly to your inbox?
The Health Resources and Services Administration has set the annual recertification of eligibility for 340B drug discounts for hospitals to begin August 15, 2018, and ends September 12, 2018. Mandatory […]
Many covered entities were recently notified that CVS had acquired 340B software vendor Wellpartner, Inc. As the 340B Program has evolved over the last several years, it is common for […]
In the past, HRSA utilized its own staff to perform 340B audits. Beginning late last year, HRSA contracted with the Bizzell Group to conduct audits on its behalf. The Bizzell […]
Webinars
For hospitals that depend on 340B savings, optimizing the Disproportionate Share Hospital (DSH) percentage that drives 340B eligibility should be treated as a financial and operational priority. In simple terms, […]
The 340B Drug Pricing Program is more than a pharmacy benefit; it is a lifeline for vulnerable communities and patients. However, as federal scrutiny and manufacturer challenges intensify, maintaining program […]
Covered entities have until Friday, March 27th to submit comments to FSSA ahead of proposed changes to eliminate 340B Program savings for Medicaid patients. The window is quickly closing for […]
Effective July 1, 2025, the state has expanded oversight of the 340B Program, requiring all hospital covered entities with a service address in Indiana to submit detailed annual reports to […]
With the exception of the COVID-19 pandemic timeframe, HRSA has long required hospital child sites to be reflected on a Medicare Cost Report prior to registration. A federal court now […]
HRSA released a request for public input on potential future pilot programs on February 17th and also released a second request on February 25th regarding the burden of a pilot […]















